QIAGEN

QIAGEN is a global provider of sample and assay technologies used across molecular diagnostics, life science research, applied testing, and pharma. Headquartered in Venlo, Netherlands, the company was founded in 1984 and has grown to become the dominant supplier of nucleic acid extraction and purification kits worldwide. The QIAamp and DNeasy kit families are ubiquitous in genomics labs, enabling reliable isolation of DNA and RNA from tissues, blood, swabs, and environmental samples. QIAGEN's QIAsymphony automation platform handles high-throughput sample processing for clinical and research settings. In molecular diagnostics, their QuantiFERON-TB Gold test is the gold standard for latent tuberculosis testing. Researchers also rely on QIAGEN for its RNeasy kits for RNA stabilization and purification, the PAXgene blood RNA system, and the QIAexpress protein expression systems. The company's Ingenuity Pathway Analysis (IPA) bioinformatics tool is widely used for interpreting genomic and proteomic data. QIAGEN's QIAcuity digital PCR system provides an alternative to droplet-based approaches, and their GeneReader NGS system offers end-to-end sequencing workflows. The breadth of their catalog and integration between sample prep and downstream assay reagents makes QIAGEN a one-stop supplier for many molecular biology workflows.